Zhengye Biotechnology Holding Limited
ZYBT
$6.70
-$2.79-29.40%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -79.52% | -79.37% | -56.79% | -57.45% | -53.05% |
| Total Depreciation and Amortization | 7.37% | 8.22% | -8.04% | -9.43% | 15.19% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 67.83% | 69.15% | -150.77% | -150.01% | -16.93% |
| Change in Net Operating Assets | -91.13% | -91.05% | 93.98% | 94.07% | 133.05% |
| Cash from Operations | -34.26% | -33.73% | 78.97% | 76.26% | 341.07% |
| Capital Expenditure | -89.29% | -90.79% | -51.50% | -49.21% | 18.94% |
| Sale of Property, Plant, and Equipment | -89.77% | -89.74% | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 97.87% | 97.86% | -- | -- | -820.11% |
| Cash from Investing | -11.63% | -12.52% | -1,262.84% | -1,242.87% | -52.41% |
| Total Debt Issued | 31.43% | 31.43% | 0.09% | 0.09% | 0.00% |
| Total Debt Repaid | -31.83% | -31.83% | -125.43% | -125.43% | 23.23% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 99.23% | 99.22% | 14.75% | 16.04% | -158.48% |
| Other Financing Activities | 33.80% | 33.80% | -- | -- | -- |
| Cash from Financing | 87.33% | 87.23% | -361.79% | -357.77% | -40.71% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 213.72% | 216.22% | -240.32% | -238.20% | 122.40% |